gastroesophageal%20reflux%20disease
GASTROESOPHAGEAL REFLUX DISEASE
Gastroesophageal reflux disease is a condition which results from the recurrent backflow of gastric contents into the esophagus and adjacent structures causing troublesome symptoms and/or tissue injury.
It is produced by various mechanisms such as frequent occurrence of transient relaxation of the lower esophageal sphincter or pressure abnormalities in the lower esophageal sphincter (which can be caused by hormonal and neural mediators, food, drugs and patient lifestyle).
Typical symptoms are acid regurgitation and heartburn.
Acid regurgitation is the perception of flow of refluxed gastric contents into the mouth or hypopharynx.
Heartburn is the burning sensation in the retrosternal region.

Surgical Intervention

Indications for Antireflux Surgery
  • Failed medical management
    • Noncompliance with therapy, medication side effects, inadequate symptom control, refractory gastroesophageal reflux disease (GERD)
    • However, surgery is generally not recommended in those who are unresponsive to PPI therapy
  • Severe erosive GERD or severe GERD complications (eg peptic stricture, Barrett’s esophagus)
  • Large hiatal hernia
  • Extraesophageal conditions (eg cough, asthma, chest pain, aspiration)
  • Young patients requiring long-term management
  • Patient preference
    • Despite success with medications, patient may opt for surgery due to cost of medications, life-long need to take acid-suppressive agents
Antireflux Surgery
  • Has evolved from open type to a laparoscopic procedure and in recent years, to transoral incisionless fundoplication
  • Surgical success is highest in patients presenting with typical GERD symptoms and demonstrating good response to treatment with proton pump inhibitor (PPI)
    • In considering antireflux surgery, inform patients regarding the risk of long-term PPI therapy after surgery
  • Esophageal manometry, ambulatory reflux studies, endoscopy and other functional testing should be done before antireflux surgery to rule out other disorders, eg achalasia, non-reflux-induced esophageal spasm, scleroderma
Fundoplication
  • Involves either a partial or a complete (360 degrees) wrap of the lower esophageal sphincter (LES) with a section of the stomach, thus, increasing LES pressure
  • Advantages include less pain, fewer incisional hernias, shorter hospital stay, quicker return to work, less defective wraps at follow-up endoscopy
  • Complications include inability to belch and vomit, persistent dysphagia, postprandial pain, epigastric fullness, bloating, temporary swallowing discomfort, intense flatus
  • Trans-oral or endoluminal fundoplication is a new modified version of an open or laparoscopic fundoplication and involves accessing the stomach through the mouth, eliminating the need for incisions
    • Is currently not recommended as an alternative to medical or traditional surgery as data are lacking to support its role
  • Recent publications have, however, noted long-term follow-up of patients who had antireflux surgery (up to 13 years post-op) showed a high rate of symptom relapse which required continuing intake of antireflux medications
  • Expertise or experience of the surgeon performing the procedure is highly predictive of clinical success
Endoluminal Treatments
  • Recent procedures, eg titanium beads implantation and full-thickness plication, intend to reduce acid reflux episodes or transient lower esophageal sphincter relaxations and increase LES basal pressure
  • Currently performed in clinical trials as durable long-term benefits have not been shown
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
10 Jan 2021
Regular practice of yoga postures confers benefits for glucose control, oxidative stress, inflammatory response, and sleep quality in patients with type 2 diabetes, a study has found.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.